glp-1 sglt2 GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Mechanisms underlying favorable effects of

A Business Insider investigation published the same day scrutinized the historical use of apparent AI-generated doctor profiles in Meta ads for MEDVi, many tied to affiliates

Boom in GLP-1 drugs augurs food industry disruption. Food Business News

The STEP-1 data show that nausea rates peak during the first four weeks and decline substantially by week 20, even as patients continue escalating toward 2.4 mg [1]

Table of Contents Understanding the link between GLP-1 therapies and hypertension How GLP-1 therapies may lower blood pressure Clinical evidence for GLP-1s in hypertension management Practical considerations for clinicians FAQs Conclusion Understanding the Link Between GLP-1 Therapies and Hypertension Hypertension and type 2 diabetes frequently coexist, creating a dangerous combination that accelerates cardiovascular disease

Neither response is wrong

Marketing for these products often suggests they work like prescription GLP-1 medications by boosting the glucagon-like peptide-1 hormone to suppress appetite and burn fat